MedPath

福建省宝诺医药研发有限公司

Ownership
-
Established
2016-05-17
Employees
-
Market Cap
-
Website
www.boroyf.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

14

NMPA:14

Drug Approvals

Ursodeoxycholic Acid Capsules

Product Name
熊去氧胆酸胶囊
Approval Number
国药准字H20253459
Approval Date
Feb 25, 2025
NMPA

Choline Fenofibrate Sustained-release Capsules

Product Name
非诺贝特酸胆碱缓释胶囊
Approval Number
国药准字H20253261
Approval Date
Jan 24, 2025
NMPA

Choline Fenofibrate Sustained-release Capsules

Product Name
非诺贝特酸胆碱缓释胶囊
Approval Number
国药准字H20253262
Approval Date
Jan 24, 2025
NMPA

Oseltamivir Phosphate for Suspension

Product Name
磷酸奥司他韦干混悬剂
Approval Number
国药准字H20253138
Approval Date
Jan 14, 2025
NMPA

Oseltamivir Phosphate Capsules

Product Name
磷酸奥司他韦胶囊
Approval Number
国药准字H20249360
Approval Date
Nov 15, 2024
NMPA

Pregabalin Capsules

Product Name
普瑞巴林胶囊
Approval Number
国药准字H20249116
Approval Date
Oct 22, 2024
NMPA

Pregabalin Capsules

Product Name
普瑞巴林胶囊
Approval Number
国药准字H20249115
Approval Date
Oct 22, 2024
NMPA

Sugammadex Sodium Injection

Product Name
舒更葡糖钠注射液
Approval Number
国药准字H20249085
Approval Date
Oct 16, 2024
NMPA

Metoprolol succinate Sustained-release Capsules

Product Name
琥珀酸美托洛尔缓释胶囊
Approval Number
国药准字H20249096
Approval Date
Oct 16, 2024
NMPA

Etoricoxib Tablets

Product Name
依托考昔片
Approval Number
国药准字H20234006
Approval Date
Aug 1, 2023
NMPA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.